Rafael Meyer, Andreas Monsch, Gilles Allali, Nadège Barro-Belaygues, Stefanie Becker, Markus Bürge, Giovanni B Frisoni, Dan Georgescu, Anton Gietl, Hans H Jung, Aurelien Lathuiliere, Kathrin Lindheimer, Karl-Olof Lovblad, Tatjana Meyer-Heim, Julius Popp, Olivier Rouaud, Marc Sollberger, Ansgar Felbecker
{"title":"[Alzheimer's disease - system prepardeness in the context of new developments].","authors":"Rafael Meyer, Andreas Monsch, Gilles Allali, Nadège Barro-Belaygues, Stefanie Becker, Markus Bürge, Giovanni B Frisoni, Dan Georgescu, Anton Gietl, Hans H Jung, Aurelien Lathuiliere, Kathrin Lindheimer, Karl-Olof Lovblad, Tatjana Meyer-Heim, Julius Popp, Olivier Rouaud, Marc Sollberger, Ansgar Felbecker","doi":"10.23785/PRAXIS.2024.11.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The possible authorisation of new monoclonal antibody therapies for Alzheimer's disease poses challenges for healthcare systems worldwide. In this paper, the Swiss Memory Clinics association (SMC) analyses the available resources and identifies potential health care shortages. Overcoming potential bottlenecks is a challenge that requires action at various levels. However, our analysis also shows that we are well positioned in Switzerland to integrate new developments into existing care structures.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"113 11-12","pages":"293-296"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Praxis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23785/PRAXIS.2024.11.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The possible authorisation of new monoclonal antibody therapies for Alzheimer's disease poses challenges for healthcare systems worldwide. In this paper, the Swiss Memory Clinics association (SMC) analyses the available resources and identifies potential health care shortages. Overcoming potential bottlenecks is a challenge that requires action at various levels. However, our analysis also shows that we are well positioned in Switzerland to integrate new developments into existing care structures.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
